International Stem Cell (ISCO) Research & Development (2010 - 2026)

International Stem Cell (ISCO) has reported Research & Development for 17 consecutive years, with $276000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development fell 3.5% year-over-year to $276000.0 in Q2 2026; TTM through Jun 2026 was $1.1 million, a 1.58% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 8.06% from the prior year.
• Research & Development was $276000.0 for Q2 2026 at International Stem Cell, down from $279000.0 in the prior quarter.
• Over five years, Research & Development peaked at $358000.0 in Q3 2022 and troughed at $263000.0 in Q4 2022.
• A 5-year average of $300058.8 and a median of $301000.0 in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development fell 21.26% in 2022 and rose 21.67% in 2023, its largest moves.
• Over 5 years, Research & Development stood at $263000.0 in 2022, then climbed by 21.67% to $320000.0 in 2023, then slipped by 10.0% to $288000.0 in 2024, then retreated by 3.12% to $279000.0 in 2025, then decreased by 1.08% to $276000.0 in 2026.
• The last three Research & Development figures came in at $276000.0 (Q2 2026), $279000.0 (Q4 2025), and $280000.0 (Q3 2025), per Business Quant data.